The FDA has approved a new breast cancer drug that avoids healthy cells while it targets tumors, reported the Associated Press. The drug, Kadcyla, is a combination of a chemotherapy drug, another drug called Herceptin, and a chemical that keeps them combined until the drug cocktail meets the tumor. Scientists…
(Reuters) – Health insurer Blue Shield of California has decided not to pay for Roche Holding’s drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California, an insure with around 3.3 million members, said in a notice posted on…